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deals with the pathogenesis, natural history, diagnosis
and management of patients with portal biliopathy.
Vascular supply of the bile duct
The arterial supply of the bile duct is through branches
of gastroduodenal artery, but it is the venous drainage
that is of particular importance in the development of
portal biliopathy.
The venous drainage of the common bile duct (CBD)
is mostly by veins that ascend along its course. They
form epicholedochal venous plexus (of Saint) and para-
choledochal venous plexus (of Petren) (Fig. 1). The
former forms a fine reticular venous plexus on the
common bile duct and hepatic ducts, and is in intimate
contact with their outer surface.6–8 The veins of this
plexus vary in size, but normally are not larger than
1 mm.The paracholedochal veins course parallel to the
CBD and are connected to the gastric veins, the pan-
creaticoduodenal vein, the portal vein and to the liver
directly.7,8 Varices of the plexus alter the normal smooth
INTRODUCTION
The changes of portal biliopathy have been reported to
be more common in patients with portal vein throm-
bosis than in patients with non-cirrhotic portal fibrosis
or cirrhosis of the liver. Unless the clinical and radio-
logical profile of this entity is well appreciated, the con-
dition could be overlooked.
Portal biliopathy is a recent terminology used to
describe biliary ductal and gallbladder wall abnormali-
ties seen in patients with portal hypertension.1–3 These
changes are predominantly seen in patients with extra-
hepatic portal vein obstruction (EHPVO) and include
abnormalities (stricture and dilatation) of both extra-
and intrahepatic bile ducts and varices of the gallblad-
der. Occasionally, these changes become significant to
give rise to overt obstructive jaundice and possibly con-
tribute to the development of choledocholithiasis.4
Biliary changes suggestive of biliopathy are reported
to be quite common in patients with EHPVO. While
some investigators have reported the ductal anomalies
in all patients with EHPVO,5 we had observed these
changes in 80% of our patients.1 The present review
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intraluminal surface of CBD and produce fine irregu-
lar mural changes.9
Pathogenesis
Bile duct varices
The earliest evidence of choledochal varices was noted
by Hunt in 1965.10 Later on, Meredith et al.11 and
others12,13 reported a few cases of common bile duct
obstruction caused by extensive collateral venous cir-
culation at the porta hepatis. These patients had varied
etiologies of portal hypertension like EHPVO, alcoholic
cirrhosis, congenital hepatic fibrosis, and few of them
were jaundiced also. The cholangiographic changes
caused by choledochal varices were first demonstrated
by William et al.14
The development of portal hypertension leads to the
opening up of numerous venous collaterals that decom-
press into the systemic circulation.15 The common col-
laterals include esophageal and gastric varices. Varices
have also been noted in the duodenum, colon, rectum,
abdominal wall, retroperitoneum and at surgical anas-
tomotic sites.
Portal biliopathy has been observed mostly in
EHPVO patients, although such changes have been
reported in a milder form in patients with cirrhosis,
non-cirrhotic portal fibrosis,1 and congenital hepatic
fibrosis. A precise explanation for a higher frequency in
EHPVO patients is not clear. In the idiopathic or
primary variety of EHPVO, which is possibly due to
omphalitis or umbilical sepsis at birth, is an early age of
onset of portal vein thrombosis and a long duration of
portal hypertension are likely to be contributory. Fol-
lowing thrombosis of the portal vein, several new col-
laterals develop, which bypass the obstruction and
produce ‘cavernomatous transformation’ of the portal
vein or formation of a ‘portal cavernoma’.11 The same
process leads to formation of collaterals around the gall-
bladder and the bile ducts.
The bile duct wall is thin and pliable, and allows pro-
trusion of the varicose paracholedochal veins into the
lumen, resulting in an appearance resembling that of
esophageal varices.11 These luminal features can be seen
better at surgery than at cholangiography.
The biliary strictures that develop in patients with 
biliopathy could form because of ischemia and vascular
bile duct injury, or prolonged compression of the biliary
tree from the portal cavernoma. Khuroo et al. have spec-
ulated that vascular injuries at the time of portal vein
thrombosis are responsible for these CBD abnormali-
ties.2 An extension of the thrombotic process may cause
ischemic necrosis of bile duct(s) and subsequent stric-
ture formation, irregularities in the caliber of the ducts
and cholangiectases. Webb and Sherlock reviewed the
presentation and natural history of EHPVO patients
and noted that out of 97 patients, 13 had an elevated
bilirubin level.16 They postulated that partial obstruc-
tion of the CBD because of mechanical compression by
engorged venous collaterals could be responsible for
this. Besides ischemia and compression, some investi-
gators have speculated an infective basis for these biliary
anomalies. Dilwari and Chawla who had observed
biliary changes in all 20 EHPVO patients studied (Table
1), called the radiological abnormalities ‘pseudoscle-
rosing cholangitis’.5 This term, however, is misleading
because cholangitis is not a common presentation of
these patients, and is rather a late event.
Clinical features
Portal biliopathy produces symptoms that are caused 
by partial or rarely, complete bile duct obstruction.
Abdominal pain, recurrent fever with chills and jaun-
dice, alone or in combination, suggests the possibility
of biliary obstruction. Majority of the patients are
asymptomatic and demonstrate characteristic changes
Figure 1 (a) Epicholedochal venous plexus. (b) Parachole-
dochal venous plexus.
Table 1 Cholangiographic abnormalities in portal 
biliopathy*
Dilwari Khuroo Sarin 
Type et al.5 et al.2 et al.1
Main bile duct 90 70 91
Left hepatic duct 100 40 83
Right hepatic duct 57 40 57
*All figures are percentages.
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on endoscopic retrograde cholangiopancreatography
(ERCP) only (Table 2). Only 14% of patients were
symptomatic in one study2 and 5% in another.5 In our
initial study, choledocholithiasis was observed in five of
23 (17%) patients.1 However, none of these patients
had biliary symptoms at onset. Only during follow up,
three of the four patients developed cholangitis, and had
to be treated with endoscopic stone extraction.
Gibson et al. reviewed 28 cases of EHPVO and
observed jaundice in five of them.17 These authors did
not specifically study the biliary abnormalities. Ductal
anomalies are likely to contribute to a large extent to
jaundice because EHPVO patients generally have near
normal liver functions.While jaundice in a patient with
portal biliopathy could be caused by the development
of a narrowing or stricture in the CBD or because of
choledocholithiasis, prolonged obstruction could lead
to the development of secondary biliary cirrhosis. In 
the majority (80%) of patients with EHPVO and portal
biliopathy, serum alkaline phosphatase levels were ele-
vated.2 However, the exact significance of raised alka-
line phosphatase is often hard to interpret if the
EHPVO patient is a child or an adolescent. The other
tests of liver function are also not helpful. However, late
in the course of the illness, the serum albumin may
decrease with derangement of coagulation functions
because of the development of secondary biliary cir-
rhosis. An abdominal ultrasound is very helpful in
establishing the diagnosis of portal cavernoma and in
the detection of venous collaterals compressing the bile
ducts and the gallbladder.18
Endoscopic retrograde
cholangiopancreatography abnormalities
Portal biliopathy changes on ERCP are protean. The
biliary abnormalities are most prominent in the
common bile duct (Table 1). The observed abnormali-
ties include: irregularities in the CBD and hepatic ducts
(i.e., smooth tapering strictures that may be single or
multiple, short or long); localized saccular dilation and
filling defects suggestive of CBD calculi etc.1,2,5 Some
of these changes are similar to those described in scle-
rosing cholangitis.2 As in recurrent pyogenic cholangi-
tis, the changes in the left hepatic duct are seen more
often in portal biliopathy. The common differential
diagnoses of this condition include CBD calculi with
associated stricture formation, biliary ascariasis and
sclerosing cholangitis. In the former, the presence of
concomitant gallstones and occurrence of CBD stones
proximal to the distal stricture provides a clue to diag-
nosis. In biliary ascariasis, linear or curved filling 
defects on ERCP and similar echogenic shadowing on
an ultrasound point to the diagnosis. Biliary anomalies
can be seen in portal hypertension caused by varied 
etiologies.
In patients with cirrhosis, pruning of intrahepatic
biliary radicles is often seen. However, in a small pro-
portion (25%) of patients with cirrhosis, cholangio-
graphic anomalies of the extrahepatic bile ducts may be
evident.19 Similarly, in approximately 40% of patients
with non-cirrhotic portal fibrosis (NCPF), cholangio-
graphic abnormalities are detectable.19 These biliary
anomalies are, however, mild.
We have proposed a simple classification for portal
biliopathy based on the location and extent of cholan-
giographic abnormalities. The diagrammatic repre-
sentation of these changes is depicted in Fig. 2 and
cholangiographic abnormalities have been shown in
Fig. 3.
Cholangiographic studies are essential for the diag-
nosis of portal biliopathy. However, ERCP is a some-
what invasive procedure. Discretion needs to be used,
especially if the patient is asymptomatic and has no
radiological or biochemical evidence of biliary obstruc-
tion. Magnetic resonance cholangiography (MRC)
could be helpful in defining the bile duct changes.
Magnetic resonance cholangiography has been shown
to be useful in several biliary tract disorders. It would
be worthwhile to compare the two modalities in diag-
nosing the condition in patients with suspected portal
biliopathy. There is little available information on the
use of radionuclide scanning in this situation.
Ultrasound abnormalities
Ultrasound studies are complimentary to ERCP find-
ings. While ERCP studies delineate the biliary ductal
changes, ultrasound provides additional information
regarding the presence of gallbladder varices, and is
thus helpful in providing the complete spectrum of
portal biliopathy changes.20 Gallbladder varices were
observed  by us in 34% of patients with EHPVO, 24%
of patients with NCPF and 13% of patients with cir-
rhosis.21 Gallbladder varices appear as tortuous dilated
vessels in or around the wall of the gallbladder, or in
the bed of the gallbladder fossa (Fig. 4). To investigate
whether these collaterals impede the contractility of the
gallbladder, motor functions of the gallbladder were
studied by us. No significant difference was noted in the
ejection fraction of the gallbladder in patients having
gallbladder varices. However, the fasting gallbladder
Table 2 Endoscopic retrograde cholangiographic abnormal-
ities in patients with portal hypertension
EHPVO NCPF Cirrhosis
ERCP changes (n = 47) (n = 10) (n = 12)
Abnormal cholangiogram 41 (87.3) 4 (40) 4 (33.3)
Extrahepatic duct 41 (87.3) 4 (40) 3 (24.9)
Left hepatic duct 34 (72.3) 2 (20) 2 (16.6)
Right hepatic duct 26 (55.3) 1 (10) 1 (8.3)
IHBR 6 (12.8) 1 (10) 2 (16.6)
Dilated Pruned Pruned
CBD stone(s) 8 (17) 0 0
ERCP, endoscopic retrograde cholangiopancreatography;
IHBR, intrahepatic biliary radicle; EHPVO, extrahepatic
portal vein obstruction; NCPF, non-cirrhotic portal fibrosis;
CBD, common bile duct. All percentages in parentheses.
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volume was found to be increased in such EHPVO
patients. The clinical significance of the latter observa-
tion remains to be determined.21
Magnetic resonance cholangiography
Because ERCP is an invasive procedure and an ultra-
sound of the abdomen may not give a definite outline
of the biliary ductal anomalies, there is a need to have
a good non-invasive modality to study biliopathy
changes. Magnetic resonance cholangiography has been
found to be helpful in the diagnosis of several biliary
tract anomalies. Magnetic resonance cholangiography
needs to be evaluated in patients with suspected portal
biliopathy and could be compared with the results of
ERCP studies.
TREATMENT
At present, strategies for the management of portal 
biliopathy are selective and directed to symptomatic
patients only (Fig. 5). Asymptomatic patients do not
need any treatment, especially if the tests of liver 
function are normal. If there is a persistent elevation of
alkaline phosphatase in a given patient with portal
hypertension, especially an EHPVO patient, then an
ultrasound, MRCP or, if needed, an ERCP could be
considered for use to detect portal biliopathy.
Choledocholithiasis is a known complication of
portal biliopathy. It was encountered in 17% of patients
Figure 2 Schematic representation of endoscopic retrograde
cholangiopancreatography changes in portal biliopathy. (a)
Type I, involvement of extrahepatic bile duct; (b) type II,
involvement of intrahepatic bile ducts only; (c) type IIIa,
involvement of extrahepatic bile duct and unilateral intrahep-
atic bile duct (left or right); (d) type IIIb, involvement of extra-
hepatic bile duct and bilateral intrahepatic ducts.
a
Figure 3 Endoscopic retrograde cholangiopancreatography
changes in portal biliopathy. (a) Type I cholangiographic
changes, (b) type IIIa cholangiographic changes; (c) type IIIb
cholangiographic changes with common bile duct stone
(arrowhead) and left hepatic duct stricture (arrow). Contin-
ued on next page.
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b c
Figure 3 Continued. See previous page for figure legend.
a b
Figure 4 (a) Gallbladder varices (GBV); (b) a Doppler study showing the flow in gallbladder varices.
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in the present study. Once stones produce obstruction
or are detected otherwise, they can be safely removed
by the use of endoscopic sphincterotomy.22,23 However,
care should be taken while performing a sphinctero-
tomy as large venous collaterals in the ampullary and
juxta-ampullary area could be present and might carry
a risk of bleeding associated with this procedure.
However, we have not encountered any complications
in the seven patients who had received sphincterotomy
at our center (GB Pant Hospital). It is important to dif-
ferentiate duodenal folds around the ampulla from col-
laterals before cutting the ampulla.There is no rationale
of giving octreotide as a preventive therapy before
sphincterotomy. The chances of bile duct stone recur-
rence are high because the primary obstructive bile duct
lesions often persist.
Sometimes, obstructive jaundice could be caused by
a dominant stricture or significant abnormalities of the
bile duct without any evidence of CBD stones. In such
patients, the placement of a biliary stent with balloon
dilation of the strictured segment of CBD is recom-
mended. The stent often needs to be exchanged and
sometimes, two or more stents need to be placed to
keep the lumen patent.
In the presence of symptomatic biliary obstruction
not amenable to endoscopic therapy, a portosystemic
shunt is indicated.24–27 This may relieve the symptoms
of biliary obstruction through portal decompression.
Biliary tract surgery in the presence of portal hyper-
tension is fraught with the danger of massive blood loss
because of unavoidable damage to collaterals that are
present in abundance in EHPVO patients.24 Hence,
biliary surgery should always be preceded by a porto-
caval shunt. Following shunt surgery, changes of portal
biliopathy have been shown to regress in most, but 
not all, patients. In a proportion of patients, bile duct
changes persist25 and produce symptoms. If these
changes get well established, surgery is probably of little
consequence in reverting them. This necessitates a
second stage surgery in the form of hepaticojejunos-
tomy to relieve the biliary obstruction.28 This lends
support to the hypothesis that ischemic changes of the
bile duct are, in part, responsible for this condition.
In conclusion, patients with portal hypertension who
have features of biliary obstruction (clinical, sono-
graphic and or cholangiographic), portal biliopathy
should be suspected as a possible diagnosis.The natural
history of portal biliopathy is ill-defined and, as men-
tioned already, varies from an asymptomatic state to the
development of various sequelae-like choledocholithia-
sis, cholangitis and secondary biliary cirrhosis. In a
single institution (GB Pant Hospital) experience of a
follow up of more than 6 years, two of 55 patients (4%)
with EHPVO and portal biliopathy have succumbed to
these sequelae. A high index of suspicion, an early diag-
nosis and clear treatment protocols would help in the
better management of this often overlooked entity.
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